Our study found that sTILS, CD45+, CD3+, CD4+, and CD8+ cells tended to have a higher frequency in tumor tissue (stromal) and that the frequencies of CD20+, FoxP3+ and CD68+ cells in tumor tissue did not change after-NAT compared with before-NAT. The gene discussed is CD68; the disease is neoplasm.